Universitätsklinikum Essen

Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registry (2025) Herrmann J, Schade J, Meybohm P, Paschke N, Hübsch ME, Notz Q, Groene J, et al. Journal article Risk of moderate or severe hypoxic ischemic encephalopathy does not correlate with prenatally known risk factors (2025) Rüdiger M, Kehl S, Wiechers C, Kribs A, Pecks U, Mildenberger E, Glaser K, et al. Journal article Needs, distress, state-of-health and quality-of-life in survivors of stage III melanoma: Results from the cross-sectional MESSAGE study (2025) Skoda EM, Jansen C, Peltz L, Schweda A, Teufel M, Livingstone E, Zimmer L, et al. Journal article Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma. (2025) Tomsitz D, Livingstone E, Loquai C, Kaatz M, Leiter U, Schilling B, Terheyden P, et al. Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Socio-economic status and tanning bed use: Results from the German National Cohort (NAKO) (2025) Görig T, Baurecht H, Günther K, Harries M, Harth V, Keil T, Krist L, et al. Journal article Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers (2025) Reitmajer M, Livingstone E, Heinzerling L, Thoms KM, Meiss F, Heppt M, Gesierich A, et al. Journal article High adherence to angiotensin-converting enzyme inhibitor in children and adolescents with Alport syndrome: objective verification using liquid chromatography-mass spectrometry (2025) Boeckhaus J, Tönshoff B, Weber LT, Haffner D, Pape L, Latta K, Fehrenbach H, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum